Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer

Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC treatment to patients with metastatic breast cancer.

The multidisciplinary team

• Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
• Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
• Patient advocate: Mrs Lesley Turner, Independent Cancer Patients’ Voice, UK

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Gilead Sciences, Inc.

This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchONCOLOGY.com